Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Exparel: Phase II/III ongoing

Pacira will begin "shortly" the Phase III portion of a 2-part, double-blind, placebo-controlled Phase II/III trial of Exparel in about 280

Read the full 213 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE